Acute tumor lysis syndrome secondary to hydroxycarbamide in chronic myelomonocytic leukemia

Am J Hematol. 2006 Mar;81(3):220-1. doi: 10.1002/ajh.20497.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Humans
  • Hydroxyurea / administration & dosage
  • Hydroxyurea / adverse effects*
  • Leukemia, Myelomonocytic, Chronic / complications*
  • Leukemia, Myelomonocytic, Chronic / drug therapy
  • Male
  • Middle Aged
  • Tumor Lysis Syndrome / etiology*
  • Tumor Lysis Syndrome / therapy

Substances

  • Antineoplastic Agents
  • Hydroxyurea